CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · Real-Time Price · USD
15.73
-0.09 (-0.57%)
Nov 21, 2024, 4:00 PM EST - Market closed
CARGO Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
116
Market Cap
724.02M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCRGX News
- 16 days ago - CARGO Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 16 days ago - CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity - GlobeNewsWire
- 3 months ago - CARGO Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director - GlobeNewsWire
- 6 months ago - CARGO Therapeutics Announces $110.0 Million Private Placement Equity Financing - GlobeNewsWire
- 6 months ago - CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 7 months ago - CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors - GlobeNewsWire
- 8 months ago - CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire